Replies to post #86305 on NorthWest Biotherapeutics Inc (NWBO)

[Docinvestor]

Progression criterias are not the same in this trial and are believed to ensure more accurate diagnosis as Linda Liau wanted that kind of patients you mention inside rather than outside when she helped design the trial.
Let's not forget that pseudoprogression is not a disease itself but a flaw in diagnosis.

Best wishes,

Docinvestor